HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recurrence patterns of advanced ovarian, fallopian tube, and peritoneal cancers after complete cytoreduction during interval debulking surgery.

AbstractOBJECTIVES:
Similar to primary debulking surgery, complete resection of all macroscopic diseases during interval debulking surgery (IDS) is the primary objective while using neoadjuvant chemotherapy followed by IDS for advanced ovarian, fallopian tube, and peritoneal cancers. However, most patients develop recurrent disease even after complete cytoreduction during IDS. This study aims to identify recurrence patterns of the ovarian, fallopian tube, and peritoneal cancers in patients who underwent complete cytoreduction during IDS.
METHODS:
We retrospectively reviewed data of patients with stage III or IV ovarian, fallopian tube, and peritoneal cancers who were treated at our hospital from January 1, 2005, to December 31, 2011.
RESULTS:
In this study, 105 patients underwent neoadjuvant chemotherapy followed by IDS and achieved complete cytoreduction. The median follow-up period was 42.1 months. Recurrence was documented in 70 patients (66.7%), and 35 (33.3%) showed no evidence of disease. Peritoneal dissemination was the most common recurrence (60.0%) observed. In multivariate analysis, positive peritoneal cytology (P = 0.0003) and elevated pre-IDS serum CA125 levels (P = 0.046) were independent risk factors for recurrence.
CONCLUSIONS:
After complete cytoreduction during IDS in patients with stage III or IV ovarian, fallopian tube, and peritoneal cancers, positive peritoneal cytology at IDS and elevated pre-IDS CA125 levels are associated with an increased risk of cancer recurrence. Positive peritoneal cytology during IDS is a particularly strong predictive factor for poor outcomes in these patients.
AuthorsTomoka Usami, Kazuyoshi Kato, Tomoko Taniguchi, Akiko Abe, Hidetaka Nomura, Akiko Yamamoto, Maki Matoda, Sanshiro Okamoto, Eiji Kondo, Kohei Omatsu, Yasutaka Kawamata, Nobuhiro Takeshima
JournalInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society (Int J Gynecol Cancer) Vol. 24 Issue 6 Pg. 991-6 (Jul 2014) ISSN: 1525-1438 [Electronic] England
PMID24905612 (Publication Type: Journal Article)
Topics
  • Cystadenoma, Serous (mortality, secondary, surgery)
  • Fallopian Tube Neoplasms (mortality, pathology, surgery)
  • Female
  • Follow-Up Studies
  • Gynecologic Surgical Procedures (adverse effects)
  • Humans
  • Lymphatic Metastasis
  • Middle Aged
  • Neoplasm Recurrence, Local (diagnosis, etiology, mortality)
  • Neoplasm Staging
  • Ovarian Neoplasms (mortality, pathology, surgery)
  • Peritoneal Neoplasms (mortality, pathology, surgery)
  • Postoperative Complications (diagnosis, etiology, mortality)
  • Prognosis
  • Retrospective Studies
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: